1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. HEPION PHARMACEUTICALS INC
Hepion Pharmaceuticals Inc XNAS: HEPA

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Hepion Pharmaceuticals Inc

The latest disclosure was made by Michael Purcell in Hepion Pharmaceuticals Inc where a trade of 50,000 Restricted Stock Units done was reported to US exchanges on March 6, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Purcell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 50,000 50,000 - - Restricted Stock Units
S. Gary Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2024 85,000 102,120 - - Stock Options
Patrick Brancaccio John Director, Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2024 85,000 99,563 - - Stock Options
Timothy Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2024 85,000 99,562 - - Stock Options
Lbiati Kaouthar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Feb 2024 85,000 88,000 - - Stock Options
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 1,200,000 1,581,060 - - Stock Options
Gary S. Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 250,000 342,785 - - Stock Options
John Patrick Brancaccio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 200,000 291,332 - - Stock Options
Thomas H. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 200,000 291,050 - - Stock Options
Robert T. Foster Director, CEO, CSO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 1,900,000 2,501,879 - - Stock Options
Petrus Wijngaard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 200,000 260,000 - - Stock Options
Timothy Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 200,000 291,276 - - Stock Options
Arnold Lippa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2021 200,000 291,110 - - Stock Options
John Cavan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.00 per share. 18 Feb 2021 10,000 14,800 (0%) 0% 2 20,000 Common Stock
Robert T. Foster Director, CEO and Director Purchase of securities on an exchange or from another person at price $ 2.00 per share. 18 Feb 2021 20,000 45,259 (1%) 0% 2 40,000 Common Stock
Petrus Wijngaard Director Purchase of securities on an exchange or from another person at price $ 2.20 per share. 16 Feb 2021 10,000 30,000 (0%) 0% 2.2 22,000 Common Stock
Peter Wijngaard Director Purchase of securities on an exchange or from another person at price $ 1.91 per share. 18 Dec 2020 20,000 20,000 (0%) 0% 1.9 38,200 Common Stock
Robert T. Foster Director, CEO and Director Purchase of securities on an exchange or from another person at price $ 1.58 per share. 08 Dec 2020 25,000 25,259 (0%) 0% 1.6 39,418 Common Stock
John Patrick Brancaccio Director Purchase of securities on an exchange or from another person at price $ 1.53 per share. 02 Dec 2020 7,000 7,008 (0%) 0% 1.5 10,710 Common Stock
Gary S. Jacob Director Purchase of securities on an exchange or from another person at price $ 1.66 per share. 01 Dec 2020 12,000 12,059 (0%) 0% 1.7 19,920 Common Stock
John Cavan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.62 per share. 25 Nov 2020 4,500 4,800 (0%) 0% 1.6 7,290 Common Stock
Timothy Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 91,276 - - Stock Options
Gary S. Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 92,785 - - Stock Options
John Patrick Brancaccio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 91,332 - - Stock Options
Thomas H. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 91,050 - - Stock Options
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 160,000 381,060 - - Stock Options
Robert T. Foster Director, CEO,CSO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 212,000 601,879 - - Stock Options
Arnold Lippa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 91,110 - - Stock Options
Peter Wijngaard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2020 30,000 60,000 - - Stock Options
Peter Wijngaard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2020 30,000 30,000 - - Stock Options
Gary S. Jacob Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 60,000 62,729 - - Stock Options
John Patrick Brancaccio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 60,000 61,275 - - Stock Options
Thomas H. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 60,000 61,051 - - Stock Option
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 215,000 221,059 - - Stock Options
Robert T. Foster Director, CEO and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 380,000 389,879 - - Stock Options
Timothy Block Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 60,000 61,220 - - Stock Options
Arnold Lippa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2020 60,000 61,109 - - Stock Options
Arnold Lippa None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 970 1,109 - - Stock Options
Timothy Block None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 970 1,220 - - Stock Options
Robert T. Foster Director, CEO and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 9,700 9,879 - - Stock Options
Gary S. Jacob None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 970 2,729 - - Stock Options
John P. Brancaccio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 970 1,275 - - Stock Options
Thomas H. Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 970 1,051 - - Stock Options
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2019 5,820 6,059 - - Stock Options
John P. Brancaccio None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 3 3 - - Series C Convertible Preferred Stock
Arnold Lippa None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 8,625 8,625 - - Warrants
Arnold Lippa None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 15 15 - - Series C Convertible Preferred Stock
John Cavan CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 15 15 - - Series C Convertible Preferred Stock
John Cavan CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 8,625 8,625 - - Warrants
John P. Brancaccio None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 1,725 1,725 - - Warrants
Gary S. Jacob None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 15 15 - - Series C Convertible Preferred Stock
Gary S. Jacob None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 03 Jul 2018 8,625 8,625 - - Warrants
John Cavan CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2018 101,221 167,947 (0%) 0% 0 Common Stock
Robert T. Foster Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2018 100,654 144,736 (0%) 0% 0 Common Stock
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2018 322,092 492,819 (0%) 0% 0 Common Stock
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2017 15,000 133,688 - - Stock Options
John Sullivan-Boyai Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2017 58,681 58,681 (0%) 0% 0 Common Stock
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2017 141,061 170,727 (0%) 0% 0 Common Stock
Robert T. Foster Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2017 44,082 44,082 (0%) 0% 0 Common Stock
John Cavan CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2017 46,726 66,726 (0%) 0% 0 Common Stock
John Cavan CFO Purchase of securities on an exchange or from another person at price $ 0.65 per share. 20 Jun 2017 20,000 20,000 (0%) 0% 0.7 13,000 Common Stock
Tamar D. Howson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2017 35,000 80,000 - - Stock Options
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2017 313,898 2,761,129 - - Stock Options
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2017 313,898 2,447,231 - - Stock Options
James Sapirstein Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2016 16,666 2,133,334 - - Stock Options
James Sapirstein Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Oct 2016 16,666 29,666 - - Common Stock
John Cavan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2016 18,688 118,688 - - Stock Options
John Sullivan-Boyai Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2016 135,790 290,790 - - Stock Options
Timothy Block None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2016 65,000 169,688 - - Stock Options
Gary S. Jacob None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2016 65,000 1,015,000 - - Stock Options
John P. Brancaccio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2016 65,000 200,656 - - Stock Options
Arnold Lippa None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2016 32,500 77,500 - - Stock Options
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2016 500,000 2,150,000 - - Stock Options
John Sullivan-Boyai Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2016 20,000 155,000 - - Stock Options
James Sapirstein Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 Feb 2016 10,000 13,000 - - Common Stock
James Sapirstein Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Nov 2015 500 3,000 - - Common Stock
James Sapirstein Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Nov 2015 2,500 2,500 - - Common Stock
William Hornung Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 15,000 165,000 - - Stock Options
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2015 150,000 1,650,000 - - Stock Options
Gary S. Jacob None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 420,000 950,000 - - Stock Options
Christopher McGuigan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 118,638 415,234 - - Stock Options
Timothy Block None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 29,911 104,688 - - Stock Options
James Sapirstein Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 500,000 1,500,000 - - Stock Options
William Hornung Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 50,000 150,000 - - Stock Options
John P. Brancaccio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2014 38,759 135,656 - - Stock Options
Timothy Block None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2014 15,000 74,777 - - Stock Options
Bernard F. Denoyer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2014 20,000 40,000 - - Stock Options
John P. Brancaccio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2014 15,000 96,897 - - Stock Options
Gary S. Jacob None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Mar 2014 300,000 530,000 - - Stock Options
John P. Brancaccio None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2014 21,897 81,897 - - Stock Options
Christopher McGuigan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2014 16,596 296,596 - - Stock Options
Timothy Block None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2014 19,777 59,777 - - Stock Options
John P. Brancaccio None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Mar 2014 4,393 6,408 - - Common Stock, par value $0.0001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters